Diabetes Africa
2023 UK Forum

Overcoming diabetes inequalities

HEALTH AND SOCIAL CARE EXPERTS IMPROVING OUTCOMES WITH BLACK POPULATIONS IN THE UK

Read the report
Back to directory

Insulet

Last update: 5 March 2024

Insulet

About

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod® 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections and zero fingerpricks.

For more information, please visit: www.omnipod.com/en-gb/hcp

More information?

This project benefitted in part from funding from partners. If you would like to help us improve and enhance the information on this page, please consider making a donation.
OK, take me to the donation page